CS logo
small CS logo
JOHAS Tohoku Rosai Hospital

Sendai Shi, Miyagi, Japan
General hospital in Sendai
4 Chome-3-21 Dainohara, Aoba Ward, Sendai, Miyagi 981-8563

About JOHAS Tohoku Rosai Hospital


  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at JOHAS Tohoku Rosai Hospital


During the past decade, JOHAS Tohoku Rosai Hospital conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 5 clinical trials were completed, i.e. on average, 55.6% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 5 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 YearsStarted TrialsCompleted Trails
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy and Bevacizumab With or Without Bevacizumab Maintenance Therapy in Treating Patients With Metastatic Colorectal Cancer
2010-03-01
2018-01-01
Completed
492
Follow-Up Care With or Without CEA Assessments in Patients Who Have Undergone Surgery for Stage II or Stage III Colorectal Cancer
2009-09-01
2021-06-01
Completed
1,997
Strategy of Early Detection and Active Management of Supraventricular Arrhythmia With Telecardiology (SETAM)
2010-07-01
2013-11-01
Completed
602
Pharmacology of Adjuvant Hormonotherapy in Breast Cancer
2010-06-17
2017-12-01
Completed
2,000
Prospective Construction and Validation of a Prognostic Score to Identify Among Patients With Metastatic Breast Cancer Those Who Benefit From a Third Line Chemotherapy in Terms of Overall Survival
2012-06-18
2023-10-01
Active, not recruiting
267
Study of Geriatric Patients Aged 75 Years or Older Treated and Cured for Localized Prostate Cancer: Case-control Study
2013-01-01
2015-02-01
Completed
74
Assessment of Intracardiac Electrograms Transmitted by Home Monitoring for the Remote Follow-up of Pacemaker (PREMS)
2014-07-01
2015-12-01
Completed
571
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
2013-06-01
2016-12-01
Completed
1,166

Rows per page:

1–12 of 12

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "JOHAS Tohoku Rosai Hospital" #1 sponsor was "Shire" with 3 trials, followed by "Arena Pharmaceuticals" with 2 trials sponsored, "Pfizer" with 2 trials sponsored, "Translational Research Center for Medical Innovation, Kobe, Hyogo, Japan" with 2 trials sponsored and "Gilead Sciences" with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "JOHAS Tohoku Rosai Hospital" #1 collaborator was "Arena is a wholly owned subsidiary of Pfizer" with 2 trials as a collaborator, "Tokyo Medical and Dental University" with 2 trials as a collaborator and "Korean Cancer Study Group" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at JOHAS Tohoku Rosai Hospital


According to Clinical.Site data, the most researched conditions in "JOHAS Tohoku Rosai Hospital" are "Ulcerative Colitis" (7 trials), "Colorectal Cancer" (2 trials), "Complex Perianal Fistulas in Adult Participants With Crohn's Disease" (1 trials), "Crohn's Disease" (1 trials) and "Gastric Cancer" (1 trials). Many other conditions were trialed in "JOHAS Tohoku Rosai Hospital" in a lesser frequency.

Clinical Trials Intervention Types at JOHAS Tohoku Rosai Hospital


Most popular intervention types in "JOHAS Tohoku Rosai Hospital" are "Drug" (11 trials), "Biological" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (5 trials), "Etrasimod" (4 trials), "Ontamalimab" (2 trials), "UFT adjuvant chemotherapy" (2 trials) and "25 mg Ontamalimab" (1 trials). Other intervention names were less common.

Clinical Trials Genders at JOHAS Tohoku Rosai Hospital


The vast majority of trials in "JOHAS Tohoku Rosai Hospital" are 12 trials for "All" genders.

Clinical Trials Status at JOHAS Tohoku Rosai Hospital


Currently, there are NaN active trials in "JOHAS Tohoku Rosai Hospital". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in JOHAS Tohoku Rosai Hospital, undefined suspended trials, and 2 terminated clinical trials to date.
Out of the total trials that were conducted in JOHAS Tohoku Rosai Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status